Genomic and transcriptomic characterization of skull base chordoma

Citations

WEB OF SCIENCE

16
Citations

SCOPUS

21

초록

Skull base chordoma is a primary rare malignant bone-origin tumor showing relatively slow growth pattern and locally destructive lesions, which can only be characterized by histologic components. There is no available prognostic or therapeutic biomarker to predict clinical outcome or treatment response and the molecular mechanisms underlying chordoma development still remain unexplored. Therefore, we sought out to identify novel somatic variations that are associated with chordoma progression and potentially employed as therapeutic targets. Thirteen skull base chordomas were subjected for whole-exome and/or whole-transcriptome sequencing. In process, we have identified chromosomal aberration in 1p, 7, 10, 13 and 17q, high frequency of functional germline SNP of the T gene, rs2305089 (P = 0.0038) and several recurrent alterations including MUC4, NBPF1, NPIPB15 mutations and novel gene fusion of SAMD5-SASH1 for the first time in skull base chordoma.

키워드

skull base chordoma; genomic characterization; transcriptomic characterization; gene fusion; T gene; GENE FUSIONS; ABNORMALITIES; GLIOBLASTOMA; REGULATOR; COMMON; IMPACT; IDH1
제목
Genomic and transcriptomic characterization of skull base chordoma
저자
Sa, Jason K.; Lee, In-Hee; Hong, Sang Duk; Kong, Doo-Sik; Nam, Do-Hyun
DOI
10.18632/oncotarget.13616
발행일
2017-01-03
유형
Article
저널명
Oncotarget
권
8
호
1
페이지
1321 ~ 1328